Oncotype score 30, weighing options and confused
Just learned that the oncotype DX score for my 1.1cm grade 2 idc is 30, so at the very top of the "intermediate risk" category. The report states 20% recurrence risk in the next 10 years with Tamoxifen alone. I initially thought "must do chemo," then my medical oncologist told me she plugged data from my actual tumor (size, grade, what the surgical pathology report listed as estrogen responsiveness of 95%, my age) into some sort of calculator Oncotype DX makes available to doctors; she said with this data added my absolute recurrence risk with Tamoxifen alone next 10 years is 11% and absolute risk using an aromatase inhibitor plus bisphosphonate (I am 59 years old but was going to use Tamoxifen due to osteopenia) is around 9%, She said my benefit from chemo would only be around 2%. The recommended chemo is 4 rounds of taxotere and cytoxan. The oncologist said I could go either way, suggested that using the AI and bisphosphonate would be equivalent to Tamoxifen plus chemo and then I could just skip the chemo. I am in my 5th week post-surgery and she said chemo needs to start no later than 8 weeks past surgery.
Have been agonizing the past 24 hours about what to do. On the one hand, would love to get the extra 2% benefit, on the other hand, I am horrified at what chemo will likely do and could potentially do to my body, especially over the long term. I'm particularly worried about vision changes (already have issues there), neuropathy (already have a little of that in one foot) and brain effects over the long haul. I'm also incredibly nervous about the anti-hormone drugs and their long-term effects, but figure with a recurrence rate in the 20s off the hormone drugs, I am going to have to at least try those.
On the one hand I think a 2% chemo benefit is not worth the collateral damage, but it makes me a little nervous that the oncologist used the estrogen level reported in my pathology report rather than the lower estrogen level shown on the Oncotype DX testing when she did he absolute risk calculator. I asked her why my score would be so high and she said likely because my cancer is PR- and "probably the Ki67 was high." When I asked her what my Ki67 level is, she said Dana Farber doesn't assess that as it "isnt reliable." I am lining up three additional local medical oncology consults next week, one at U-M Comprehensive Cancer Center. Fouling up the process is that the D-F lab has apparently lost my pathology slides, and these are needed for the U-M consult. Has anybody here ever had that happen? Was the lab able to recut slides from whatever tumor was left? Praying those turn up soon.
Really would appreciate input re your decision-making process regarding chemo, especially if your oncotype score was in the high "intermediate" range, but oncologist said absolute benefit from chemo was low. Trying to decide whether, if I get mets down the line, I would be okay with a decision not to do chemo figuring I would know that I still had risk whether or not the chemo was done... or whether I would be kicking myself for not doing it and getting that tiny edge.
Thanks in advance for any input. Worst day since diagnosis.
Comments
-
sos, so sorry you are dealing with this! Tough decisions. I was 58 at DX. My onco score was 21. As you can see,(after much thought), I opted for chemo. I am otherwise healthy, but I still worried about long-term SE's. I had 4 rounds of TC. My thought process was, that I wanted to do everything I could, while I could and not have regrets should the beast reappear down the road. If it's any consolation, my SE's were minimal and my MO said I was her poster child! She told me I could go either way. I have a family history, although my BRCA was neg. It is a lot to process. You might want to get a second opinion. I am on Tamoxifen with no SE's, now. I did have my MO reduce my last dose of Taxotere due to a reaction. I have no regrets. There is no guarantee with or without chemo. Good luck with your decisions. PM if you wish.
-
Thanks, keepthefaith, it's great to hear that you were able to tolerate the chemo so well--cytoxan and taxotere x4 is also what my oncologist suggested. I'm also pretty healthy right now (except for osteopenia), just hoping like crazy I can stay that way and still beat the cancer. I so miss feeling well and not living with this awful fear. Did you get a port for your chemo or just a regular IV?
Part of my thinking is since my tumor is PR- and apparently not actually 95% ER+ as stated in my pathology report the hormone therapy may not work that great and chemo may be my best shot. The decision-making is so hard, I really worry about dementia down the line and stuff like that, but I guess I could also consider that it would be good to live long enough to have to worry about that. I will definitely be getting a couple of second opinions.
-
Sos, good luck do what you think will be best for you. Can also do cold caps for hair, ice for mouth sores and they have pretty good anti nausea. One of my friends had wicked diarrhea from chemo, I hate it because you so little control.
-
FWIW, 2% added benefit from chemo is not much. (But that’s just my opinion). The percentage given on the chart is for local recurrence over the next 15 years. With chemo added, you have only a 2% less chance of 15-year recurrence than with an AI. There are other online tools that figure out life expectancy as well. In my case, the difference worked out to 6 extra months of life expectancy, getting me to 84-1/2 rather than 85 years before statistically buying the farm. (Not worth it, I decided, and my MO agreed). I don’t know why only the calculator tool available to physicians factors in AI therapy whereas the chart released to patients assumes Tamoxifen. Unless you have significant contraindications to AI therapy, it’s more effective in postmenopausal women than is Tamoxifen and carries less risk of heart attack, stroke and endometrial cancer.
You have to look at your comorbidities (other conditions you have that might be made seriously worse by chemo) such as preexisting heart and lung issues, immune system, etc. For some people, peripheral neuropathy that is sometimes a side effect can be a deal-breaker if they need sensation in their fingers or toes for their careers (musicians, dancers, surgeons). Others may have serious respiratory issues that might make infections caused by immunosuppression life-threatening. I have asthma and major antibiotic allergies, and even with immune boosters might not survive a serious infection were I immunosuppressed. (Oddly, I was less upset by the prospect of hair loss than by that of losing my eyelashes). Fortunately, for me it never came to that. One of the reasons they do an Oncotype DX is to guesstimate whether your tumor’s micromets would even be vulnerable to chemo, which kills rapidly dividing cells. The rationale is that a Grade 1 or 2 hormone+/HER2- node-negative IDC<2cm in an older woman is slow-growing enough that chemo would have more impact on normal cells in the rest of the body than on any micromets.
-
Reading all over this board about Oncotype test. The nurse practitioner of my oncologist called with my result . It was 11 , she said doctor would go over all the info on Thursday with me and his recommendation. I'm hoping the number is low enough for no chemo . I'm already scared enough about taking tamoxifen, can't imagine throwing chemo into the mix .. I guess what scares me the most is there never seems to be a perfect answer. How do I know I don't have some random crazy cancer cell hanging out somewhere . Don't want to have a pity party but feel this roller coaster ride will never stop
-
BosumBlues, the 2% recurrence rate quoted by my oncologist was the result she got when she plugged some pathology report tumor stats into a "physicians only" calculator Oncotype DX offers on their website. Until I understand better how she reached that conclusion, I'm pretty uncomfortable assuming that is true. Will be getting three other consults and hope to see what other docs get with same calculator.
I agree, it really is a crapshoot. We all just have to be able to live with our decisions, it's just about killing me that I have to make a rather huge decision in next two weeks with information that is not exactly solid.
-
rose50, thanks so much for the advice about asking for CMF rather than TC, I will definitely look into that. Meow13, I am figuring to get a cold cap if I end up getting chemo. Also thinking to ask about ice gloves and boots if such things exist to help stave off neuropathy, or just putting on rubber gloves and sticking my hands and feet into ice buckets if the infusion office will permit that. Really hoping to keep the collateral damage as minimal as possible, the long-term SEs scare the crap out of me.
-
ChiSandy, I'm getting 4 additional medical oncology consults and am hoping, hoping, hoping they all (or at least a majority) agree that the chemo benefit would be 2%. At that point I could pretty easily decide to forego it. What has me a little concerned is that my tumor (at least according to oncotype dx) appears to be slightly less than 50% ER+ and PR-, so not sure the hormone therapy will work all that well. The medical oncologist from Dana Farber was originally suggesting Tamoxifen for 2 years followed by AI due to my existing osteopenia. Now she's suggesting AI with a bisphosphonate--both also scare me, but given my apparent recurrence risk I will definitely try my best to tolerate the hormone therapy. The onc said AI with bisphonsphonate would put me at a recurrence risk of around 7-9%.
I was so sure I wouldn't need chemo I haven't even researched it until this week. Still hoping I can avoid it, I already have healthy eating habits and am willing to ramp up the exercise since that apparently also reduces risk. This is going to be a wild couple of weeks.
-
SOS, in case you haven't seen this and are interested, here is a link to an article that describes the different parts that factor into the Oncotype recurrence score. There is a lot of science here, but I found the equation in Figure 1 very interesting - it shows how ER lowers the score. PR is part of the group ER score, so we can't determine how the two independently affect the score.
-
Live4them, I can definitely empathize. Looks to me based on the information you provided that chemo won't be recommended. At least with hormone therapy you can get off the ride if the SEs are too much. Chemo is such a scorched-earth thing, once you start it may be hard to completely erase whatever SEs happen.
Fingers crossed you get good news, just seems as though with low oncotype score and the features of your tumor you would escape chemo.
-
Sos1125- thanks for the words of encouragement ❤️
-
sos, yes, I had a port placed when they did my LX and SNB. Most people probably wait until after the surgery, so they can be staged, but I didn't want to do SX again, so went for it. It was kind of annoying at first, but you get used to it. It sounds like you are on the right track!
-
I can sympathize. I hope you look closely at the link jo jo provided. I wonder if your MO was using cancer math or adjuvant rather than an Oncotype formula.
Info from traditional pathology results don't always match Oncotype. I was told by Genomic Health directly that 30% of grade 3's have low Oncotypes, for instance. I suggest you call Genomic Health's customer service line to talk to them. In many ways they were more helpful to me than my doctors. They are highly trained.
You are under some time pressure and it is good, if unpleasant, that you know that.
Here is my case if it helps: I was grade 3, high ki67 (20), with lymphovascular invasion but negative nodes. I had one positive HER 2 test (from biopsy) and one negative HER 2 test. I was 95% ER+ and 80% ER+. My Oncotype score was 8, which was a surprise. I was ready for the worst.
The first two MD's, based on the HER2 +, got me ready for chemo and Herceptin. Then I got a negative HER2 and we waited on the Oncotype. When it was low, I asked my second, main oncologist if he would retest HER2 and reorder Oncotype. Genomic Helath agreed with me and said they would do it with MD request. The second MD refused to do this and the tumor board had said no chemo.
Third MD went along with second MD and was very cheery. But said second MD was one of her best friends (ha ha). So on to fourth MD.
Fourth MD looked at grade 3, LVI, high KI67, one HER2+ and said "this is a tumor that wanted to go somewhere." She also said "I don't blame you for being troubled." She got me an echocardiogram and a wig Rx and went to bat for me in many ways:
She retested the HER 2 with more cells counted, so more thorough- results, negative.
She talked with Genomic Health and got a retest of the Oncotype: came back exactly the same, at 8. That means 6% risk with hormonal treatment. And overall- and this is the big point from the Oncotype- chemo would hurt more than help. Cancer might benefit slightly, but mortality would be worse. And with my age and other health issues, a big no, finally, to chemo. At this point I was 11 weeks out from surgery- not a good time frame so lucky it worked out this way.
But I had to keep going to be sure.
Aromatase Inhibitors are not as bad as you might think. Exercise is important. I recently was in despair about joint pain and stiffness and took care of a dog this past week, who needed to walk an hour/day. Now I feel great. The winter weather had discouraged me from walking. I started with 1/4 dose and ramped up, which helped my body adjust. Your body reacts to the change, yes, but in a few months it adjusts.
With an Oncotype score of 30, I would have done chemo. I was thinking that anything over 18 I would consider it. Do you have a paper copy of your report? The charts on there are very helpful in explaining what the numbers mean.
I do not understand why you have different ER scores. This is VERY important. The ER is key in the Oncotyping. It is possible that your tumor is heterogeneous and is higher in one area than another. Talk to Genomic Health. Maybe you can get both your ER/PR tested and the Oncotype redone. I am hoping your Oncotype was done post surgery, not post biopsy, because the biopsy isn't always the best pathology to rely on.
Bottom line for your decision is to clarify the ER/PR, especially the ER. Hormonal therapy will be the most important if you are truly 98/95. But your Oncotype score would be lower, much lower, if this was the case. (Unless you are HER2+.) Your MD is using the higher ER/PR in telling you about the 2% benefit with chemo. If your ER/PR is indeed lower, as Oncotype says, your benefit from chemo would be higher and your risk without it higher.
Make sure you get the true results for ER/PR and also talk to Genomic Health.
Finally, yes my slides and blocks got lost and I had to track them down. Since I dealt with 4 hospitals and with Genomic Health twice, my slides and blocks did a lot of moving around. Sometimes someone in pathology could not locate it but I did, by calling around. Sometimes one part of a hospital knows where they are (lab) but another part doesn't (MD). I got to know all the assistants in all these pathology labs by name and very well and am deeply grateful for their help moving my slides all around the city. My kids told me that my slides were "promiscuous"!
ps Editing to add that I believe- and others can confirm- that Genomic Health grinds the tumor and gets a score that takes several different areas into account, so off the cuff, I would trust them more than pathology result on ER. Genomic Health can tell you about this on the phone.
-
jojo9999, thanks very much for the link, I had not seen that article. I'm wondering whether the data represented in chart B on page 38 is where my oncologist got the "2% absolute benefit from chemo" statistic given my score of 30--I mean that this is incorporated into the calculator on the oncotype DX website. Still, I noticed in the recent Taylorx study that they threw scores something like 26 and up into the "high risk" group and gave them chemo. Definitely makes me nervous regardless of my first onc's risk assessment. Kind of nauseated to contemplate the 3 additional oncologist appointments I have next week, I know a decision has to be made soon.
Thanks again for the information, I appreciate it.
-
Thanks, keepthefaith. I'm kind of freaked out by the port, but everything I've read says it's the easiest way to get chemo, if you must get it.
-
". . . What has me a little concerned is that my tumor (at least according to oncotype dx) appears to be slightly less than 50% ER+ and PR-. . "
sos:
I assume you have a copy of the original report from that, but if not, please obtain a copy. Read all the small print in the ER information section.
From page 3 of this sample report, it appears that they report an individual ER score and PR score separately from the combined Oncotype Recurrence Score (which is a combined score incorporating the results of multiple genes). But the ER score is given as a numerical score on this sample report, not as a percentage. Is yours reported as a percentage, or do you mean the arrow is landing in the green zone, but at the lower end?
http://breast-cancer.oncotypedx.com/en-US/Professi...
Under the "Clinical Experience" heading in that section, they mention some correlation with ER score and benefit of tamoxifen, but I would want a professional medical oncologist's opinion on the strength of any data behind that statement and how you should view it in your thinking, especially if you may be using an AI.
At page 3, it is also noted that the individual ER and PR scores may differ from ER and PR status determined by different methodologies.
This 2012 paper is a little heavy going, but by my read, they seem to take the view that, for purposes of determining endocrine therapy, immunohistochemical methods (traditional pathology) are more sensitive and preferred to the quantitative mRNA measurements made by RT-PCR reported by GenomicHealth:
http://www.nature.com/modpathol/journal/v25/n6/ful...
They are also somewhat critical: "The additional reporting of qRT-PCR ER and PR results on oncotype report confuses clinicians and unnecessarily creates doubt about validated immunohistochemistry assays."
The above is for information only, and subject to confirmation with your providers. There may be additional, more current, and/or conflicting studies which speak to the question of the clinical implications (if any) of such differences or to the level of validation surrounding the Oncotype individual ER score. Be sure to add any questions you have about the individual ER score to the list of things to discuss with your MOs to ensure accurate and current professional advice and sound conclusions about the meaning of the report.
BarredOwl
-
windingshores, this is enormously helpful, thanks. Hadn't even occurred to me to call Genomic Health. I do have serious concerns about the variable reports of tumor estrogen level. I was figuring to ask the various oncologists I will see which is more accurate, the stains they do at the pathology labs or the molecular testing. On a logical level it would make more sense that, if the pathologists are simply eyeballing the degree of staining, the molecular test would be more accurate; however, I don't know whether pathologists have a more objective way of evaluating staining (I intend to find out). My PR came in weakly positive (5%) on my biopsy report, but I realize they were only sampling a tiny spot of the tumor there.
Glad to hear your missing slides turned up, gives me hope. Mine will also be well traveled. ;o)
-
sos - what is being looked at pathologically is not estrogen level, but rather the number of receptors on a slide of 100 cells. The percentage does not indicate how "estrogenic" the tumor is, but how much it can be fueled by estrogen. The percentage given on the report is how many of those cells, out of 100, have estrogen receptors. That is how you get the derived percentage - say you have 50 out of 100 cells showing estrogen receptors, for that slide you have 50% ER+. It is also important to note that tumors are not homogenous - two different slides can show a differing number of receptors if the slide is taken from a different spot on the tumor.
-
My Oncotype score would likely have been far lower had my ER been higher than 72%--but my PR was 97%, so that definitely landed me on the “low" side of the "low vs. intermediate" divide. Genomic Health measures chemo benefit by how rapidly your tumor cells appeared to have been dividing--the slower they divide, the less likely cytotoxic chemo would be to kill them and the more likely it would kill mostly your faster-dividing “normal” cells such as epithelial (mucosa) and hair follicles instead. With a lower % of ER & PR and a higher mitotic rate score and tumor grade than, respectively, 1 and 2--as well as a positive HER2 result--my Oncotype score would have been higher and the benefits of chemo might have outweighed the risks. There’s at least one person here who, despite being at the high end of “low” (17) opted for chemo. (She cold-capped and kept half her hair, but because it was unusually thick to begin with nobody could tell she’d had any loss). I still don’t know why the calculator tool available to patients assumes Tamoxifen rather than an AI as hormone therapy, since the average age of onset is 61--very few women are still perimenopausal at that age.
My MO chose letrozole as the AI for me because it’s the third-generation AI and showed greater efficacy and lesser incidence of onerous SEs in women with higher BMIs. Most of my ER+ friends who were slender to begin with were given anastrozole or exemestane, at least initially.
-
It might be because in order to have long-term recurrence information to correlate with Oncotype Recurrence Scores, it was necessary to use tissue samples from relatively older trials. (The selection of trials would also be subject to availability of suitable stored tissue samples and adequate patient consents, so they probably didn't have a big selection to choose from.) Thus, the trials used to first validate the Oncotype test were National Surgical Adjuvant Breast and Bowel Project (NSABP) trials B-14 and B-20, regarding tamoxifen and chemotherapy. If the calculator were based on the results of these initial validation studies (which have the long term data), then it would reflect the endocrine therapy used in those studies (i.e., tamoxifen). Just my thoughts.
BarredOwl
-
I had a grade 3 with high Ki67 but the Oncotype was so low that chemo would, according to them, be harmful and of little benefit. It is really hard when tests conflict, or when the treatment that pathology would seem to suggest doesn't match up with Oncotype. That can work both ways, meaning, high or low Oncotype being unexpected. MD's expected me to be happy but I am still troubled some by the mismatch and my fate was in many ways decided on based on the Oncotype rather than traditional pathology.
SOS I think you have a different picture but a similar challenge in terms of conflicting tests. I really hope that the three appointments give you clarity or at least a feeling that you can move ahead more sure than not. If you relied on the Oncotype alone, you would most likely have chemo. Check the paperwork if you have it (or get it) and yes Genomic Health can be helpful. Most important I think is an MD you can trust.
I think that some docs don't rely on the Oncotype as much as others, frankly. I don't know if this means they are sensible or old-fashioned! I don't really understand where your first MO was coming from with the 2% but if you can find out whether that is valid, and based on a Genomic Health physician site, that would indeed be an argument against chemo.
Good luck. I remember the inertia I felt after surgery. I didn't have my usual go getter personality and delayed some of the opinions too long (also my daughter had surgery, other stuff). You are getting your opinions at a good time, but it is tiring to contemplate. I promise once you've seen the other docs you will feel so much better and surer!
-
sos:
Did you see my earlier post about the individual oncotype ER scores, with link to sample report and 2012 paper? We may have cross-posted. Hopefully, some of the information will be of use as you frame your follow-up questions for your MOs.
Your approach is very thorough, and you will arrive at a well-founded and informed decision, which is the best that anyone can do.
BarredOwl
-
A Mamma-print test may be an option for you also, since you have an intermediate score...but, more waiting. I didn't do one, but was offered it. Did not want to muddy my brain any more or wait any longer to start TX. If you are going to get one, I would have your MO order it sooner than later.
-
Barred Owl, thanks for the information and links. I do have the report, my ER score is 8.0, so yes, on the lower side of the "positive" bar. Figuring that tumors are heterogenous and immunohistochemical methods sample small tumor areas rather than masses of tissue ground together but are maybe more sensitive, I'm thinking the truth may lie in between my 95% ER+ score and my apparent lesser score on the Oncotype test.The information about non-tumor tissue getting ground in and skewing the Oncotype DX results also makes sense. I am really going to have to rely on the expertise of the oncologists in interpreting which test is more reliable as there are so many variables to take into account.
SpecialK, thanks for clarifying that the reported ER+ and PR+ is referring to receptors rather than hormones and offering an explanation of how the testing is done. I truly need to learn more about the pathologic review process since my life is depending on it.
ChiSandy, part of what's confusing me about my test results is that the mitotic rate on both my biopsy and surgical pathology reports is 1. So seems to me the tumor would be less aggressive and I would have received a lower score. My oncologist said the Ki67 in my "proliferative rate" score must have been high, but when I asked her how much Ki67 my tumor had she said Dana Farber doesn't measure that because it is "not reliable." I did ask about doing a Mammaprint test and she said "we don't do that." If I thought I had time to wait for results, I might insist on it at this point. Does anybody know how long it takes to get that done?
Further complicating my situation is the fact that my original pathology slides are lost in the U.S. Mail. If you can believe it, I had the Dana Farber pathology lab send my slides to MD Anderson for a surgical pathology second opinion prior to learning my Oncotype DX score. Chemo was not on my radar, I was quite sure that would not be needed based on pathology reports and the information I received from surgeon/M.O./R.O. After I learned the score, scrambled to find a local oncologist at a comprehensive cancer center and landed at University of Michigan CCC (driveable and much easier on my kids than me being in Boston). When I called MD Anderson to ask them to cancel my second opinion and just return the slides so U-M could use them, learned that slides never arrived, and on contacting the Dana Farber-affiliated hospital lab I learned that the pathology staff sent the slides First Class U.S. Mail with NO TRACKING. So I have appointments at U-M next week, but no slides... and they will not treat without doing their own pathology review. Just called Dana Farber lab this afternoon and insisted they recut slides from whatever is left of my tumor and send U-M SOMETHING to work with via FedEx. Still hoping the original slides show up as I wanted U-M to review another questionable point on my pathology report: surgeon said there was a main 1.1cm tumor and then right next to that a .3mm tumor... so multi-focal, which I've read has a worse prognosis, albeit she said this is not uncommon and not a big deal and she would not say this gave me a worse prognosis. So yesterday I requested the operating room notes for my consults and learned one of the "cavity shave margins" she did is from the actual tumor chunk not the cavity (and same margin where the .3mm tumor was shown)... so now am wondering whether I actually had one larger 1.4cm tumor that she cut through when she did the "cavity shave" margin. And also wondering whether there will be enough tumor left after the recut to do a Mammaprint test if there's time. And hoping U-M will do the Ki67 testing, I am definitely going to ask them to do that. And seriously thinking I am about to lose my mind trying to sort it all out.
Windingshores, in my perfect world I do my 3 additional oncology consults next week and all of them agree that my benefit from chemo would be 2%. That would truly be the best thing that's happened to me in weeks, I am so dreading the mere thought of chemo I can hardly get my brain around the possibility that it may seem necessary enough to risk it. Just have to wish the treatments were kinder and more effective and that the decision-making was not such a nightmare.
Thanks to all for the information and support, I truly appreciate it.
-
Dear SOS:
I wish you the best of luck. You are going for many 2nd opinions which, I think, is very wise. You have done a great deal of research and I hope that these doctors can answer your questions in a satisfactory manner. It is very stressful to have to make such a difficult decision. Good luck with your choice and with your tx. I will pray for you and send you hugs.
Dear Live4Them:
Good luck.
Dear WindingShores, BarredOwl, Jojo, and KeepTheFaith:
Thanks for all of the informative posts and links.
Dear Rose:
I am so sorry that you are in so much pain and that you continue to have such serious side effects from chemo. Hugs, prayers, and positivity to you. I wish you well.
FYI:
I am taking Arimidex/Anastrazole and I have no side effects. Maybe you won't either if you will be taking an AI or Tamoxifen. Good luck.
-
SOS, my Oncotype was 30 also. It gave me a 4% benefit from chemo. My MO loves statistics and was not convinced I needed chemo until I had the Mammaprint test. Mammaprint does not have the intermediate category and I fell in the high risk category. I got the port and I have had no issues. I had the four rounds of TC. During round 3 I had a problem with fluid buildup and the MO lowered my Taxotere by 20% for the last round. Other than that, the SEs were minimal and very manageable. I lost my hair but it grew back (except for an area where I had alopecia before the cancer diagnosis). It's a tough decision, but honestly I was leaning toward doing the chemo before the Mammaprint test confirmed it for me. Not sure if this helps you at all, but thought I would share.
-
SOS did you get the address that DF used in mailing the slides? Were they sent "attention to" a particular person or MD? Were they sent to pathology or to the doctor's office or to the cancer center?
I thought my slides were lost when DF sent them to a certain hospital. The oncology office did not know where they were. I had someone looking for them. But when I called pathology directly, and was given a supervisor to talk with, she managed to find them. There are other situations I won't go into but basically sometimes the right hand doesn't know what the left hand is doing in these hospitals. If you can get a person in pathology to try to track them down, that might help. Or maybe you already have. It is also possible they have been returned and are lost at DF or in the process of being reentered in the system.
Those slides MUST be somewhere. It is very unlikely they were lost in the mail.
Those original slides were presumably chosen as most representative for your cancer.
Where is the block that Genomic Health had for the Oncotype? Was it returned to DF?The Mammaprint is a good idea. Maybe another MD will order it, and the block sent to Genomic Health could be used.
You are at 7 weeks post surgery? I was told 12 weeks was the outside limit for chemo after surgery but 8 is no doubt better. The time pressure is so hard.
Has anyone offered to start you on hormonal therapy while you wait? How does your current MO view the discrepancy in results on hormonal receptors? I felt a little better taking Femara while I made decisions, though don't know if that meant the more extended time with new testing (I was at 11 weeks post surgery) was addressed by the Femara.
Man, I know just how you feel. I remember this period very well. You will find a more peaceful time within a few weeks. Whatever we decide, we make peace with I think. The bottom line is that we hope for the best no matter what we do, and during all of this we learn there is no certainty and, for me at least, that the science is far from where I thought it was in terms of understanding cancer, period.
-
sos1125 Hi there. Like you my oncotype score was 27 and I opted out of chemo with the approval of my MO. I also have not yet taken an anti hormone. Im 62 and already have a debilitating autoimmune disease. Im much more concerned about QOL than chance of recurrence. When I questioned my MO about my 18 percent recurrence rate she told me that the way they calculate the numbers are 30 years old and not reliable! She said my actual recurrence rate is much lower. Really? We can't do better than that? In addition she also told me there is actually no way to monitor a recurrence until it is stage 4 and causes symptoms! Really? IMO we need much more research to find improved prevention, treatment and yes cure rates.....
-
Thanks, cubbleblue, for sharing your experience. I have asked for MammaPrint testing, just hope I can get it done within my rapidly closing window of opportunity.
Windingshores, the good news is my missing pathology slides finally did turn up today, albeit I'm still in fear they will ultimately not make it to my U-M appointments as the slides were sent back to D-F and then I will have to trust that the D-F lab will follow through and send them by FedEx as requested. IMO the way D-F handles slides is way not appropriate for an institution that's supposed to be world class, and that is an understatement. The pathologist answering an email from my surgeon actually stated that they send slides through regular mail "because of the cost factor." Just realized I am going to have to request FedEx for the MammaPrint testing, it just blows my mind that they will send tumors through regular mail.
At this moment am just so depressed about the entire scenario. Just feel as though I'll be killing myself if I take all the chemo and drugs, and killing myself if I don't. Seems like such a no-win situation. Hopefully tomorrow will be a better day, just having a hard time handling the fear.
Thanks again for the input, I appreciate it.
-
dtad, I hear you about QOL. Am also wondering whether screwing my system up with all the drugs is ultimately going to be what kills me... but also terrified to not follow "standard of care." It's really hard to know who to believe.
Thanks for weighing in.
Categories
- All Categories
- 679 Advocacy and Fund-Raising
- 289 Advocacy
- 68 I've Donated to Breastcancer.org in honor of....
- Test
- 322 Walks, Runs and Fundraising Events for Breastcancer.org
- 5.6K Community Connections
- 282 Middle Age 40-60(ish) Years Old With Breast Cancer
- 53 Australians and New Zealanders Affected by Breast Cancer
- 208 Black Women or Men With Breast Cancer
- 684 Canadians Affected by Breast Cancer
- 1.5K Caring for Someone with Breast cancer
- 455 Caring for Someone with Stage IV or Mets
- 260 High Risk of Recurrence or Second Breast Cancer
- 22 International, Non-English Speakers With Breast Cancer
- 16 Latinas/Hispanics With Breast Cancer
- 189 LGBTQA+ With Breast Cancer
- 152 May Their Memory Live On
- 85 Member Matchup & Virtual Support Meetups
- 375 Members by Location
- 291 Older Than 60 Years Old With Breast Cancer
- 177 Singles With Breast Cancer
- 869 Young With Breast Cancer
- 50.4K Connecting With Others Who Have a Similar Diagnosis
- 204 Breast Cancer with Another Diagnosis or Comorbidity
- 4K DCIS (Ductal Carcinoma In Situ)
- 79 DCIS plus HER2-positive Microinvasion
- 529 Genetic Testing
- 2.2K HER2+ (Positive) Breast Cancer
- 1.5K IBC (Inflammatory Breast Cancer)
- 3.4K IDC (Invasive Ductal Carcinoma)
- 1.5K ILC (Invasive Lobular Carcinoma)
- 999 Just Diagnosed With a Recurrence or Metastasis
- 652 LCIS (Lobular Carcinoma In Situ)
- 193 Less Common Types of Breast Cancer
- 252 Male Breast Cancer
- 86 Mixed Type Breast Cancer
- 3.1K Not Diagnosed With a Recurrence or Metastases but Concerned
- 189 Palliative Therapy/Hospice Care
- 488 Second or Third Breast Cancer
- 1.2K Stage I Breast Cancer
- 313 Stage II Breast Cancer
- 3.8K Stage III Breast Cancer
- 2.5K Triple-Negative Breast Cancer
- 13.1K Day-to-Day Matters
- 132 All things COVID-19 or coronavirus
- 87 BCO Free-Cycle: Give or Trade Items Related to Breast Cancer
- 5.9K Clinical Trials, Research News, Podcasts, and Study Results
- 86 Coping with Holidays, Special Days and Anniversaries
- 828 Employment, Insurance, and Other Financial Issues
- 101 Family and Family Planning Matters
- Family Issues for Those Who Have Breast Cancer
- 26 Furry friends
- 1.8K Humor and Games
- 1.6K Mental Health: Because Cancer Doesn't Just Affect Your Breasts
- 706 Recipe Swap for Healthy Living
- 704 Recommend Your Resources
- 171 Sex & Relationship Matters
- 9 The Political Corner
- 874 Working on Your Fitness
- 4.5K Moving On & Finding Inspiration After Breast Cancer
- 394 Bonded by Breast Cancer
- 3.1K Life After Breast Cancer
- 806 Prayers and Spiritual Support
- 285 Who or What Inspires You?
- 28.7K Not Diagnosed But Concerned
- 1K Benign Breast Conditions
- 2.3K High Risk for Breast Cancer
- 18K Not Diagnosed But Worried
- 7.4K Waiting for Test Results
- 603 Site News and Announcements
- 560 Comments, Suggestions, Feature Requests
- 39 Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts
- 4 Survey, Interview and Participant Requests: Need your Help!
- 61.9K Tests, Treatments & Side Effects
- 586 Alternative Medicine
- 255 Bone Health and Bone Loss
- 11.4K Breast Reconstruction
- 7.9K Chemotherapy - Before, During, and After
- 2.7K Complementary and Holistic Medicine and Treatment
- 775 Diagnosed and Waiting for Test Results
- 7.8K Hormonal Therapy - Before, During, and After
- 50 Immunotherapy - Before, During, and After
- 7.4K Just Diagnosed
- 1.4K Living Without Reconstruction After a Mastectomy
- 5.2K Lymphedema
- 3.6K Managing Side Effects of Breast Cancer and Its Treatment
- 591 Pain
- 3.9K Radiation Therapy - Before, During, and After
- 8.4K Surgery - Before, During, and After
- 109 Welcome to Breastcancer.org
- 98 Acknowledging and honoring our Community
- 11 Info & Resources for New Patients & Members From the Team